Obesity is increasing in the population as a whole, and especially in the obstetric population, among whom pregnancy-induced physiological changes impact on those already present due to obesity. In particular, changes in the cardiovascular and respiratory systems during pregnancy further alter the physiological effects and comorbidities of obesity. Obese pregnant women are at increased risk of diabetes, hypertensive disorders of pregnancy, ischaemic heart disease, congenital malformations, operative delivery, postpartum infection and thromboembolism. Regional analgesia and anaesthesia is usually preferred but may be challenging. Obese pregnant women appear to have increased morbidity and mortality associated with caesarean delivery and general anaesthesia for caesarean delivery in particular, and more anaesthesia-related complications. This article summarises the physiological and pharmacological implications of obesity and pregnancy and describes the issues surrounding the management of these women for labour and delivery.
Obesity is an emerging international health issue, particularly in developed countries, and has significant implications for the obstetric population. It is most commonly classified using the parameter of body mass index (BMI), which is the ratio of weight to height (kg/m 2 ) 1 . A normal BMI in the non-pregnant adult is defined as 20 to 24.9, overweight as 25 to 29.9, obese as 30 to 39, morbidly obese as 40 to 49.9 and super morbidly obese as >50 1 . Recent data from both Australia and New Zealand estimates that over 25% of the adult population is obese and that the incidence appears to be increasing [2] [3] [4] .
In the obstetric population, obesity can be difficult to define because of the physiological weight gain associated with pregnancy. The normal maternal weight gain from baseline is 10 to 16.7 kg and the foetal-placental unit typically represents 35% of this gain 5 . Body mass index is normally calculated from the pre-pregnancy weight, or the first weight measured during antenatal care 6 . Alternatively, the definition 'obese' includes women who are 110 to 120% of their ideal body weight or >91 kg (200 lb) 7 . In Australia 20% of parturients are overweight, 12% obese and almost 2% are morbidly obese 8 .
Obesity is associated with a substantial increase in both obstetric and anaesthetic related morbidity, as well as being a significant risk factor for maternal mortality 6, 9, 10 . In a recent Confidential Enquiry into Maternal and Child Health report from the United Kingdom, more than half the women who died from direct or indirect causes were overweight or obese and more than 15% were either morbidly or supermorbidly obese 11 .
This review aims to outline the physiological and pharmacological changes that occur when an obese woman becomes pregnant. It then discusses the obstetric and obstetric anaesthetic implications of moderate and severe obesity, including suggestions for the safe anaesthetic management of these women.
PHYSIOLOGICAL CHANGES
Pregnancy induces a number of dramatic physiological changes to support the utero-placental unit 12 , which are maximal towards the end of the third trimester. Obesity also results in a number of significant physiological changes which worsen with increasing BMI. The combination of these changes stresses a number of organ systems that function near their physiological limits.
Respiratory changes
Within the airway, pregnancy causes capillary engorgement and mucosal oedema, due to an increased blood volume and elevated oestrogen levels 13 . With concurrent obesity, these changes are compounded by soft tissue adiposity 13 . The increased fat deposition in the chest wall and abdomen, when added to the cephalad movement of the diaphragm associated with normal pregnancy, decreases the functional residual capacity (FRC), residual volume and expiratory reserve volume 14 . Total compliance decreases as a result of increased pulmonary blood volume, reduced FRC and decreased chest wall compliance 14, 15 . These changes are potentially exacerbated by the supine, lithotomy and Trendelenberg positions which are frequently used during labour and general anaesthesia 14 .
Functional residual capacity often falls below closing capacity in obese patients, resulting in shunting 14, 15 . The apices of the lungs are preferentially ventilated, which further worsens the V/Q relationship 14 . This in part explains why low arterial oxygen tensions are more commonly found in obese parturients. The work of breathing in obese parturients is increased due to the reduced chest compliance and greater chest wall weight 6, 15 . This leads to a relative restrictive respiratory defect associated with a rapid, shallow breathing pattern 16 . Oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) increase linearly with body weight 16 . Minute volume is further elevated due to increased sensitivity of the medullary respiratory centres to CO 2 , an effect of progesterone 17 . A summary of changes in the respiratory system is shown in Table 1 .
Pregnant women are predisposed to obstructive sleep apnoea, despite protective stimulatory hormonal effects during pregnancy. The true incidence of obstructive sleep apnoea is unknown as the condition may go undiagnosed 18 . While 7.6% of non-pregnant women aged 30 to 49 years experience sleep disordered breathing 19 , pregnant women exhibit higher rates of snoring, indicating upper airway obstruction during sleep 20 . The incidence of snoring may double with increasing body weight, reaching 25% in the obese population 21 . As well as having maternal implications (including systemic and pulmonary hypertension, coronary artery disease, somnolence and arrhythmias), significant desaturation 18, 20 .
Cardiovascular changes
The cardiovascular system undergoes very significant changes during pregnancy, while obesity results in marked changes in cardiac, endothelial and vascular function. Cardiac output increases by up to 50% during pregnancy 22 and obesity has been estimated to increase cardiac output by 30 to 50 ml/minute for every 100 g of adipose tissue 23 . Blood flow is distributed to adipose-rich tissues, with relative sparing of the cerebral and renal vessels due to autoregulation 24 . Blood volume rises in pregnancy and further with obesity, although obesity tends to reduce the ratio of blood volume to mass 24 . The physiological anaemia normally seen in pregnancy is exacerbated in the obese patient by increased activity of the renin-angiotensin system, but partially offset by secondary polycythaemia 24 .
Endothelial dysfunction occurs in the obese parturient as a result of high plasma leptin, insulin and inflammatory mediators such as C-reactive protein, IL-6 and TNF alpha 9 . This endothelial dysfunction predisposes to hypertension and offsets the afterload reduction seen as a result of decreased systemic vascular resistance in pregnancy 9, 25 . In the obese parturient, the myocardium adapts to hypertension by left ventricular hypertrophy and in severe cases dilatation that eventually leads to systolic dysfunction 6,9 . In addition, diastolic dysfunction may develop because of a reduced diastolic time (increased heart rate), left ventricular hypertrophy and fatty infiltration of myocardial tissue 6, 24 . Finally, pulmonary pressures may rise due to a combination of left ventricular dysfunction, increased pulmonary blood volume, sleep apnoea, hypoxia and the supine position, with the potential for pulmonary hypertension and cor pulmonale 6 .
Obese parturients are at an increased risk of gestational and peripartum arrhythmias 6, 25, 26 . Myocardial hypertrophy and dilatation, fat deposition in the conducting system, ischaemic heart disease, elevated catecholamines and sleep apnoea have been implicated 24 . Minor QT prolongation significantly increases the risk of sudden death and drugs that affect the QT interval, such as granisetron, droperidol and methadone, should potentially be avoided 6, 27 . Obesity is an associated risk factor for peripartum cardiomyopathy, but of greater importance is that it makes this condition more difficult to diagnose. Symptoms of cardiac dysfunction may be masked and there are technical difficulties in performing echocardiography 6 .
Aorto-caval compression by the gravid uterus in pregnancy is well documented, but a similar situation, termed the "Obese Supine Hypotensive Syndrome" can occur in the non-pregnant obese individual. These two conditions are likely to increase the risk of hypotension, syncope and reduced uterine blood flow if the supine position is assumed, especially during regional anaesthesia 6, 9, 10, 27 .
Gastrointestinal changes
Obesity and pregnancy independently elevate the intra-abdominal pressure, relax the lower oesophageal sphincter, reduce gastrointestinal motility and, possibly, increase gastric acidity and volume 10, 27 . Gastric emptying may also be delayed secondary to autonomic dysfunction in association with pre-existing diabetes mellitus 28 . These changes may lead to an increased risk of regurgitation, with the potential for airway obstruction and aspiration pneumonitis 9, 27 .
Metabolic changes
Poor glycaemic control can occur from the effects of obesity, the metabolic syndrome and pregnancy, mediated by elevated human placental lactogen, human chorionic gonadotrophin and steroid hormones, which increase the resistance of target tissue to insulin. Oestrogen accelerates the insulin secretion from pancreatic beta cells 27 and hyperlipidaemia occurs.
OBSTETRIC IMPLICATIONS
Obesity is associated with reduced fertility secondary to a number of reproductive system changes and anatomical difficulties 29, 30 . Despite this, pregnancy is still frequently achieved. Obesity confers a number of pregnancy-related risks for both the mother and the foetus 29 and some of these risks appear to positively correlate with increasing body mass index.
Foetal congenital malformations such as neural tube defects occur more frequently 29 and early pregnancy loss is more common [31] [32] [33] . Maternal obesity is a strong predictor of both childhood obesity and long-term metabolic dysfunction 34, 35 . It has been recommended that obese women receive preconception counselling to reduce the risks related to pregnancy for both themselves and their babies 36, 37 . Pre-conception or ante-natal counselling may assist these women in limiting weight gain during pregnancy 29 .
Diabetes
Gestational diabetes (GDM) results from insufficient insulin production to offset the relative insulin resistance of pregnancy 38 39 . In one study the incidence of GDM in obese women was 17% compared with 1 to 3% in non-obese women 40 .
Obese pregnant women also have a higher incidence of pre-existing type 2 diabetes 41 . Type 2 diabetes can mimic GDM but has more serious neonatal and maternal implications, such as foetal congenital malformations, foetal macrosomia and more maternal cardiovascular and renal complications [42] [43] [44] [45] . It is reported in 2.6 to 70% of those earlier diagnosed with GDM, the greatest cumulative increase occurring in the first five years postpartum 38, 46 .
Hypertension
Obese women have higher rates of pre-conception chronic hypertension than women with a normal BMI 47 . Hypertension diagnosed during pregnancy may reflect previously undiagnosed essential hypertension or be due to pre-eclampsia, for which obesity, insulin resistance and hypertriglyceridaemia are important co-factors. Hypertensive disorders of pregnancy have been shown to be more common in overweight (OR 2.0, 95% CI 1.8 to 2.2) and obese women (OR 3.3, 95% CI 3.0 to 3.7) [48] [49] [50] . The risk of preeclampsia doubles with each 5 to 7 kg/m 2 increase in BMI 49 and the incidence in obese women is between 10 to 25% 33, 49 . Postulated mechanisms are the combination of endothelial dysfunction, oxidative stress and inflammation 51 .
Labour and delivery
Obese women are more likely to progress past term gestation 31 and often require induction of labour 29 . Obesity is a risk factor for a number of labour complications. Antepartum ultrasound can be technically challenging 52 and foetal monitoring during labour more difficult due to attenuation of ultrasound waves by abdominal wall adiposity 53 .
Induction of labour in obese women has been associated with high failure rates (14.6% vs 7.9% in non-obese parturients in one study) 29 , while vaginal birth after caesarean delivery has been demonstrated to be less successful in obese and morbidly obese women (OR 1.99, 95% CI 1.20 to 3.30 and 2.22, 95% CI 1.11 to 4.44, respectively) 54, 55 . Obese women have slower rates of cervical dilatation 56 so are more likely to need augmentation of labour, as indicated by the need for oxytocin (57% vs 40%) and early amniotomy (26% vs 15%) 36 .
Vaginal delivery is more difficult because of high rates of cephalopelvic disproportion (6% vs 1% in obese versus non-obese women) and has been associated with a higher incidence of shoulder dystocia (OR 3.6, 95% CI 2.1 to 6.3) as a result of foetal macrosomia and soft tissue dystocia 29, 31, 57 . Maternal body habitus may make manoeuvres to manage shoulder dystocia less successful 29 .
Operative vaginal delivery is more likely with increasing BMI (obese women 17.3% vs non-obese 8.4%), while higher rates of third/fourth degree perineal tears and difficulties with repair can complicate post partum care 58 .
Caesarean delivery
Rates of both elective and emergency caesarean delivery are two to four times higher amongst obese women 36, 39, 48, 59 . Postulated reasons are maternal obstetric complications and increased rates of induction, relative dystocia and primary uterine inertia (thought to be related to higher levels of plasma leptin, an oxytocin antagonist) 29, 31, 60 .
As well as anaesthetic complications, there are two major areas of obstetric risk relating to operative delivery. The first is postpartum haemorrhage, with it being demonstrated that obese parturients are more likely to receive uterotonic drugs 31, 61 and experience blood loss greater than 1000 ml (OR 5.2, 95% CI 1.4 to 21.1) 61 . The second is more post-operative cystitis, wound and pulmonary infections 62 .
Surgery is more challenging in the obese patient and usually takes longer to perform 61 . Access to the uterus may require retraction of the panniculus, which can cause significant cardiovascular compromise 9 and greater postoperative pain 29 . Close communication between the surgeon and anaesthetist is necessary and specialised equipment or additional staff may be required.
Bariatric surgery
Pregnancy after bariatric surgery appears to be safe. Following Roux-en-Y or laparoscopic gastric banding procedures, women have less pre-gestational and gestational diabetes, hypertension, preeclampsia, obstructive sleep apnoea 63 and reduced rates of foetal macrosomia 64 .
Nutrition may be affected after predominantly malabsorptive procedures, and some authors recommend nutritional supplementation 64, 65 . Case reports describe incidents such as gastrointestinal haemorrhage and internal intestinal herniation, which are known complications of bariatric surgery. Band-related complications appear to increase during pregnancy, perhaps due to nausea and vomiting in the first and second trimesters [65] [66] [67] [68] and some institutions remove saline from the adjustable gastric band to allow normal weight gain and avoid band slippage.
The effect on oesophageal motility and reflux symptoms is unclear. Merrouche et al found an increased incidence of gastro-oesophageal reflux symptoms after laparoscopic gastric banding and a reduced incidence following the Roux-en-Y procedure, whereas Korenkov et al found no change in reflux symptoms after laparoscopic gastric banding, but improved function of an incompetent lower oesophageal sphincter 69, 70 .
Rates of caesarean section appear to be slightly increased, independent of the confounders of obesity and previous caesarean section 71 .
ANAESTHETIC IMPLICATIONS
Anaesthesia for labour and delivery Regional anaesthesia
The provision of regional analgesia and anaesthesia reduces the need for systemic opioid analgesia during labour and the use of general anaesthesia for caesarean delivery. As the obese parturient is more likely to require emergency operative intervention 29, 36, 39, 48, 58, 59 and general anaesthesia confers greater risks 72 , neuraxial analgesia early in labour is recommended 27 .
Epidural anaesthesia in the obese parturient is often more difficult to perform and is associated with higher failure rates 61, 73 . While BMI per se is not an independent predictor of difficulty, landmarks are more difficult to palpate in obese women and back flexion is limited. Both of these are predictors of difficult neuraxial placement 74 . Successful epidural catheterisation often requires more than one attempt 61 , epidural catheters fail more often 73 and are more likely to migrate 75 . Despite the potential for an increased depth to the epidural space, the relationship between depth and BMI is not strong 27 . It is unusual to encounter the epidural space at a depth greater than 80 mm 76,77 , so a standard 80 mm Tuohy needle should be used initially 27 .
Suggested techniques to facilitate neuraxial blockade in the obese parturient include the use of the patient's light touch discrimination to determine the midline 78 , tilting of the table towards the operator to facilitate opening of the lumbar interspaces 9 and use of a seeker needle to identify a spinous process 79 . Lumbar soft tissue ultrasound may prove to be useful. It has the potential to determine midline structures, the correct interspace and the depth to ligamentum flavum, but is technically challenging 27, 80 . Combined spinal epidural techniques have the advantage of the presence of cerebrospinal fluid as a reliable indicator of midline needle insertion 27 . The seated position facilitates landmark discrimination in the obese patient and also reduces the distance from the skin to the epidural space, but is detrimental with respect to increased venous engorgement (and hence increased risk of vascular cannulation or injury), slower cephalad spread of local anaesthetic and catheter migration on the resumption of the lateral position 27, 75, 76, 81 . A longer length of epidural catheter (5 to 6 cm) should be inserted to account for the greater catheter movement common to this patient population.
The spread of epidural solution can be inconsistent in the obese parturient, with the potential for greater cephalad spread because of increased epidural fat and venous distension reducing the capacity of the epidural and subarachnoid space 10, 82 . Total local anaesthetic requirements may be less and if careful titration is not used, high block can lead to haemodynamic and respiratory embarrassment 83 . Because of the increased incidence of poor quality or failed epidural block, some advocate the placement of a spinal catheter 27 . This has the advantage of providing greater consistency and reliability and dural puncture headache after this technique may be lower in this population 84, 85 .
Accidental dural puncture
The obese obstetric patient is at higher risk of accidental dural puncture during neuraxial blockade, some units reporting incidences of up to 4%, compared to 0.5 to 2.5% in the non-obese population 27, 73, 84 . Difficulty locating the epidural space due to the increased depth and false loss of resistance are considered contributing factors 9,10,80 . Despite the higher incidence of accidental dural puncture, the risk of subsequent post dural puncture headache may be lower in the obese parturient 10,27,84,85 , possibly because higher abdominal pressures increase the epidural space pressure and limit cerebrospinal fluid leakage.
Anaesthesia for caesarean delivery
The obese parturient often requires delivery by caesarean and is more likely to experience prolonged surgery, an anaesthetic complication, post-partum haemorrhage or wound infection 6, 9, 10, 39, 48, 61, 62, 72, 86 .
Maternal death reporting has found that the majority of anaesthetic deaths arise from complications of general anaesthesia 11,72 so early antenatal anaesthetic consultation 9,37 and regional anaesthesia are widely recommended.
General considerations Pharmacological
There are a number of complex and interacting pharmacological changes associated with both obesity and pregnancy. These relate to alterations in relative proportions of fat and lean body weight, cardiac output, blood volume and regional blood flow which may affect drug peak plasma concentrations, volumes of distribution, clearance and elimination 87 . Most dosing recommendations are based on total body weight (TBW), although this fails to take into account the differing proportions of fat and lean body mass (LBM, the difference between TBW and fat mass), which increase disproportionately. The LBM is proportionally related to both cardiac output 88 and drug clearance 89 and can be estimated using the equations:
With respect to intravenous anaesthetic drugs, thiopentone is highly lipid soluble and hence the volume of distribution is markedly greater in obese patients 91 . A smaller dose is required for induction than in non-obese patients (3.9 vs 5.1 mg/kg) 91 and it has been recommended that the standard induction dose of thiopentone be calculated based on LBM 87, 92 . The volume of distribution and clearance of propofol rises with increasing body weight and it has been suggested that maintenance dosing be based on TBW 92 , while induction doses tend to parallel those in lean subjects if based on LBM 87 .
The situation with volatile anaesthetic drugs is more complex. A reduced FRC leads to decreased dilution of volatile by alveolar gas, which combined with an increased cardiac output in the obese hastens the rise in F A /F I for sevoflurane 93 . In these patients the rate of equilibration between F A and F I differs between the volatile anaesthetics, with a slower rise seen with the more soluble drugs such as isoflurane 94 . The equilibration of F A /F AO is slightly slower in the obese, owing to storage of anaesthetic in the larger lean tissue and fat compartments. This is offset by a greater cardiac output, returning agent from the tissues to the lungs 95 . In addition, the time constants for equilibration in fat are long (1350 to 2110 minutes) for all these drugs, while blood flow to fat decreases with increasing obesity, limiting pharmacokinetic effects from increased fat mass 87 . While differences exist between the solubility of sevoflurane and desflurane in both blood and fat, various studies have shown either a small or no difference between clinical endpoints of awakening, cognition and return of airway reflexes following anaesthesia in obese patients using desflurane or sevoflurane 93, [96] [97] [98] . The differences generally become evident only after anaesthesia of three hours duration or more. Over the expected duration of a typical general anaesthetic for caesarean delivery, the clinical difference in offset between volatile anaesthetics would be expected to be negligible.
Muscle relaxants are poorly lipid soluble and are distributed to a limited extent in body fat 99 . Metabolism is also unaffected by obesity, although if dosed according to total body weight a prolonged duration of action is more likely 92 , and hence nondepolarising neuromuscular blocking drug dosing should be calculated from ideal body weight. Suxamethonium distributes similarly to the nondepolarising drugs but the activity of pseudocholinesterase can be enhanced in obesity as a result of increased metabolic activity. Thus the recommended dosing of suxamethonium is in accordance with total body weight 92 . Use of a nerve stimulator would appear prudent owing to these uncertainties about the duration of neuromuscular blockade.
Neostigmine displays a ceiling effect, at between 0.035 to 0.07 mg/kg, because of maximal antagonism of acetylcholinesterase. Given that the drug is insoluble in fat, a relative overdose is probably administered in the obese when administered according to total body weight. Following dosing based on total body weight, reversal of atracurium in obese and non-obese patients was unchanged 100 .
Opioids are highly lipid soluble drugs that are distributed evenly between lean and fatty tissue, showing similar clearance in the obese and nonobese patient 101, 102 . Initial loading should be on a total body weight basis, as elevated cardiac output in the obese rapidly re-distributes the drug from the plasma and leads to lower peak plasma concentrations. Clearance of fentanyl and alfentanil correlate linearly with lean body mass 88 , suggesting repetitive dosing be based on this measure. Remifentanil volumes and clearances correlate with lean body mass, while dosing according to total body weight leads to supra-therapeutic plasma levels 103 .
Positioning
Care must be taken when positioning patients in the operating theatre to prevent injuries to both staff and the patient 37 . The management of an obese parturient requires adequate staffing to facilitate transfers, as well as training in manual handling techniques. The use of bariatric hover mattresses, self transfer by the patient and minimising the number and complexity of staff led transfers is prudent 104,105 . oBesIty And oBstetrIC AnAestHesIA Anaesthesia and Intensive Care, Vol. 39, No. 4, July 2011 Some patients may require two adjacent operating tables, or special purpose tables with side-arms, to accommodate their increased girth. The maximum operating weight limit of the table should not be exceeded.
Irrespective of the recommendation to provide regional anaesthesia, conversion to general anaesthesia remains a possibility, so optimal positioning is important. A ramped position has been suggested, whereby pillows or wedges are used to elevate the head and shoulders such that the external auditory meatus and sternal notch are aligned 106 (Figure 1 ). As well as optimising access for direct laryngoscopy, elevation of the head of the bed improves the FRC, aiding pre-oxygenation should general anaesthesia be required 107 .
Monitoring
Reliable monitoring of obese obstetric patients is essential to the provision of safe care. Non-invasive blood pressure monitoring may either be impossible or inaccurate due to the difficulty in finding an appropriately sized blood pressure cuff. Cuffs that are too small overestimate blood pressure, which might delay the recognition and management of haemorrhage. Invasive monitoring with an arterial cannula is often useful 27 , while central venous catheters may provide more durable venous access as well as adding haemodynamic information.
Regional anaesthesia
Regional anaesthesia is preferred despite the potential technical difficulties. Single shot spinal anaesthesia is familiar and often suitable, but in morbid obesity in particular, a combined spinal epidural technique has been recommended 27 . This is because the spinal dose requirement is more difficult to predict. Furthermore, with a combined spinal epidural technique, the block can be extended if surgery is prolonged. A reduced dose of bupivacaine has been recommended for the obese and morbidly obese woman (in our institution 11 mg of hyperbaric bupivacaine is commonly used) because there is the likelihood of a smaller cerebrospinal fluid volume, while large buttocks align the spine in a Trendelenberg position [108] [109] [110] [111] encouraging cephalad spread. A high block is of particular concern because it worsens respiratory impairment caused by spinal anaesthesia for caesarean delivery 83 , while augmenting the respiratory changes associated with obesity that lead to hypoxaemia.
Older studies in parturients and non-pregnant patients receiving spinal anaesthesia show an increased block height associated with obesity [110] [111] [112] . However a recent study found that there was no statistically significant difference in ED 95 between obese and non-obese parturients 112 .
General anaesthesia
Obese women undergoing general anaesthesia for caesarean delivery are over-represented in maternal mortality reports, with issues related to intraoperative and postoperative airway management.
Traditional management of general anaesthesia for caesarean section focuses on rapid attainment of adequate depth of anaesthesia, with provision of cricoid pressure and endotracheal intubation.
Airway management
The pregnant woman is at greater risk of a difficult (approximately 1 in 30) or failed (approximately 1 in 250) intubation compared to her non-pregnant counterparts 73, 113 and obesity appears to further increase this risk. In one study, difficult intubation was noted in 13% of the general surgical population 15 versus 33% among morbidly obese women 6 . With obesity, mask ventilation may prove difficult due to reduced chest wall compliance and increased intra-abdominal pressure 13 . Desaturation is also significantly faster with obesity, especially in patients in labour, where the time taken to desaturate after the onset of paralysis may be as short as 40 seconds 115 . A head-up position 107, 115, 116 and nasopharyngeal insufflation of oxygen may assist in prolonging the time to desaturation 117 . Preparation for difficult airway management is mandatory, for example attention to appropriate positioning, aspiration prophylaxis and well rehearsed difficult and failed intubation drills. While data exists suggesting the safety of laryngeal mask anaesthesia in the fasted, non-obese parturient undergoing elective caesarean delivery under general anaesthesia 118 , this approach cannot be currently recommended in the obese obstetric patient, except in an emergency situation in which other methods of airway management have been unsuccessful.
Pulmonary aspiration
Pulmonary aspiration accounts for a significant proportion of airway issues encountered during obstetric care 72 . Physiological changes to the airway and gastroesophageal junction, pain and opioids, variable fasting periods and the emergency nature of delivery predispose to regurgitation and aspiration. Obese parturients in labour are thought to have higher gastric volumes, a higher incidence of hiatus hernia and elevated intragastric pressure 27 . Repeated attempts to obtain a patent airway during inadequate anaesthesia may also increase the risk of regurgitation. In obese pregnant women strategies to minimise risk include the use of H 2 antagonists, non-particulate antacids and rapid sequence induction with cricoid pressure, with placement of a cuffed tracheal tube 119 .
Postoperative care
Body mass index is inversely correlated with respiratory function following spinal anaesthesia 83 and obese pregnant women appear to be at approximately twice the risk of pulmonary complications such as hypoxaemia, atelectasis and pneumonia, venous thromboembolism and pulmonary oedema 61, 73 .
Oxygen may be beneficial in the post anaesthetic care unit or ward to offset a tendency to hypoxaemia as a result of both residual regional block and existing alterations in pulmonary function.
Postoperative infective complications such as endometritis, urinary tract infection and wound complications (including dehiscence) are more prevalent 36, 61, 73 , leading to a greater likelihood of prolonged postoperative hospital stay 61 .
Analgesia
Following general anaesthesia without neuraxial blockade, analgesia options are limited and generally based on systemic opioid via a patient controlled intravenous analgesia technique (using fentanyl or morphine) or as requested orally (using oxycodone, morphine or tramadol) 120 . Little evidence supports administration of intramuscular or subcutaneous opioids, mainly because of patient dissatisfaction. Careful opioid dosing and use of dose-sparing strategies are vital considerations to avoid respiratory depression in the sleep-disordered patient.
Paracetamol is an efficacious and safe adjunct that may be combined with non-steroidal antiinflammatory drugs when the latter are not contraindicated. This combination can be opioid sparing 121 , although the effect of non-steroidal anti-inflammatory drugs on platelet and renal function, particularly in preeclampsia or postpartum haemorrhage, needs consideration.
Local anaesthetic instilled in the wound or for ilioinguinal, iliohypogastric and transversus abdominis plane blocks are adjunctive therapies that offer benefit but may be technically difficult to perform 120 .
Venous thromboembolism
Thromboembolic disease is a major cause of maternal mortality in developed countries 11, 122 and both caesarean delivery (especially emergency surgery) and obesity are major risk factors 123 . Obese parturients are at higher risk of events during early pregnancy (OR 2.7, 95% CI 1.5 to 4.9), throughout pregnancy (9.7; 3.1 to 30.8) and during the puerperium (2.8, 0.8 to 9.8) 124 . Low molecular weight heparin is recommended for antenatal and postnatal thromboprophylaxis. It has been suggested that an increased dose is used for the obese pregnant woman, and continued for at least seven days post partum 122 . A suggested regimen is illustrated in Table 2 .
The Royal College of Obstetricians and Gynaecologists recommend thromboprophylaxis for three to five days after spontaneous vaginal delivery among women over 35 years of age who have a prepregnancy or early pregnancy BMI >30 or weight >90 kg; and for three to five days following caesarean delivery for women who have a prepregnancy or early pregnancy BMI >30 or weight >80 kg. Consideration should be given to thromboprophylaxis for all obese parturients who are hospitalised antenatally, irrespective of the reason 122 .
In addition to pharmacologic prophylaxis, postpartum exercise should be encouraged and mechanical methods such as graduated compression stockings and sequential calf compression devices employed.
CONCLUSION
The obese obstetric patient provides a challenge to the novice and experienced anaesthetist alike. As well as serious and wide-ranging physiological alterations, a number of obstetric and anaesthetic complications are increased. Due to the increasing prevalence of obesity in women of childbearing age, it is likely that the anaesthetist will be called on to care for an increasing number of these challenging patients. The safe care of these women requires careful planning and preparation, which should ideally begin at the pre-conception stage.
